Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

BridgeBio Pharma (BBIO) Interest & Investment Income (2019 - 2025)

BridgeBio Pharma (BBIO) has disclosed Interest & Investment Income for 7 consecutive years, with $4.3 million as the latest value for Q4 2025.

  • Quarterly Interest & Investment Income fell 7.5% to $4.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $19.9 million through Dec 2025, up 15.1% year-over-year, with the annual reading at $19.9 million for FY2025, 15.1% up from the prior year.
  • Interest & Investment Income hit $4.3 million in Q4 2025 for BridgeBio Pharma, down from $6.2 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $6.2 million in Q3 2025 to a low of $182000.0 in Q4 2021.
  • Historically, Interest & Investment Income has averaged $3.2 million across 5 years, with a median of $4.0 million in 2024.
  • Biggest five-year swings in Interest & Investment Income: plummeted 79.7% in 2021 and later skyrocketed 2148.35% in 2022.
  • Year by year, Interest & Investment Income stood at $182000.0 in 2021, then surged by 2148.35% to $4.1 million in 2022, then skyrocketed by 36.31% to $5.6 million in 2023, then fell by 16.05% to $4.7 million in 2024, then decreased by 7.5% to $4.3 million in 2025.
  • Business Quant data shows Interest & Investment Income for BBIO at $4.3 million in Q4 2025, $6.2 million in Q3 2025, and $3.9 million in Q2 2025.